August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds fro ...
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 8, 2012 — At this year’s SNM Annual Meeting, June 9-13, Philips Healthcare is highlighting its portfolio of nuclear ...
May 18, 2012 - New research from the University at Buffalo suggests that cardiologists may have a new way to identify ...
April 27, 2012 — More than 150 molecular imaging professionals gathered last week at the Society of Nuclear Medicine’s ...
April 9, 2012 — After witnessing a downtrend for several years, revenues in the U.S. nuclear medicine and positron ...
April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and ...
March 22, 2012 – Addressing concerns over radiation from cardiac imaging and procedures, the American College of ...
January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear ...
January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology LLC ...
January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about ...
January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac ...
January 5, 2012 – During RSNA 2011, TeraRecon Inc. demonstrated a suite of innovative tools for its iNtuition solution ...
December 16, 2011 — Positron Corp. announced this week that on Dec. 12, 2011, its Attrius & Attrius L positron emission ...
August 03, 2012